Prognostic impact of prior local therapy in castration-resistant prostate cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyab019
Abstract: OBJECTIVE This study aimed to reveal the prognostic values of prior local therapy in first-line therapy using androgen receptor-axis targeting agents (abiraterone or enzalutamide) or docetaxel for castration-resistant prostate cancer (CRPC). METHODS The study included… read more here.
Keywords: prostate cancer; prior local; local therapy; castration resistant ... See more keywords